Marius Pharmaceuticals Receives PDUFA Date for KYZATREX® NDA for Treatment of Hypogonadism
11 mars 2021 10h00 HE
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., March 11, 2021 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) goal...
Life Extension's clinically-studied nutritional supplement supports healthy urinary function
02 févr. 2021 10h00 HE
|
Life Extension
Fort Lauderdale, FL, Feb. 02, 2021 (GLOBE NEWSWIRE) -- No guy likes waking up in the middle of the night to “go.” But for many men, it isn’t an option: nocturnal urination leads to sleepless nights...
Marius Pharmaceuticals Announces Co-CEOs Himanshu H. Shah and Shalin Shah to Drive Growth ahead of Anticipated FDA Action of its Lead Asset, KYZATREX
28 janv. 2021 10h00 HE
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a specialty pharmaceutical company focusing on treating conditions that are primarily associated with testosterone...
Conversion Labs Annualized Revenue Run-Rate Hits $53.9 Million, up 332% vs. 2019, Driven by Subscriptions to an Expanding Suite of Telehealth Brands
15 déc. 2020 08h31 HE
|
Conversion Labs, Inc.
NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a direct-to-consumer telemedicine and wellness company, reported its annualized revenue run-rate reached a record...
Conversion Labs July 2020 Revenues up 302% to Record $3.6 Million, Remains on Track to Exceed $40 Million in Revenue in 2020
03 août 2020 08h31 HE
|
Conversion Labs, Inc.
NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported record revenues of $3.6 million in the month of...
Clarus Therapeutics Announces Commercial Launch and Availability of JATENZO® (testosterone undecanoate) capsules, CIII for the Treatment of Hypogonadism
10 févr. 2020 08h00 HE
|
Clarus Therapeutics, Inc.
First and only FDA-approved oral treatment of its kind for testosterone deficiency1,2 NORTHBROOK, Ill., Feb. 10, 2020 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc. today announced that JATENZO®...
Clarus Therapeutics Expands Executive Team in Preparation for Landmark Launch of JATENZO® (testosterone undecanoate) Capsules CIII
11 déc. 2019 14h04 HE
|
Clarus Therapeutics, Inc.
NORTHBROOK, Ill., Dec. 11, 2019 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc. today announced the appointment of five senior leaders, each of whom bring valuable industry and category experience to...
BioReference Laboratories Supports Man Cave Health During National Men’s Health Month
07 juin 2019 07h00 HE
|
Bio-Reference Laboratories
ELMWOOD PARK, N.J., June 07, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., along with its specialty oncology and urology division, GenPath, announce today their support of Man Cave...
Ultimate Sports, Inc. (USPS.pk) Releases "Chairman's Update"
15 janv. 2019 11h02 HE
|
Ultimate Sports, Inc.
Lafayette, IN, Jan. 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Ultimate Sports, Inc. (USPS.pk), a Medical Sexual Health Therapeutics Provider, announced today that the company’s Chairman, Dr....
Naturopathic Doctors Help Address Top Men’s Health Concerns with Lifestyle Changes and Natural Therapies
01 juin 2018 09h00 HE
|
Institute for Natural Medicine
Seattle, June 01, 2018 (GLOBE NEWSWIRE) -- Despite new data showing a rise in advanced prostate cancer, men are more likely than women to skip doctor visits. With higher rates of heart disease,...